Long COVID Research Moonshot Act
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Long COVID Research Moonshot Act (S. 4964) is a Senate bill introduced in the 118th Congress aimed at advancing research on Long COVID, a condition involving prolonged symptoms following COVID-19 infection. The bill was read twice and referred to the Senate Committee on Health, Education, Labor, and Pensions but ultimately failed or expired without further legislative action. No official summary or full text is available, limiting detailed analysis of specific provisions or funding mechanisms.
This bill sought to promote research on Long COVID but did not progress beyond committee referral and expired without enactment.
- The bill was introduced in the Senate during the 118th Congress and referred to the Committee on Health, Education, Labor, and Pensions.
- Its focus was on Long COVID research, addressing ongoing health concerns related to post-COVID conditions.
- The bill status is marked as failed or expired, indicating it did not advance to become law.
['Researchers and scientific institutions focused on Long COVID and related health conditions', 'Individuals suffering from Long COVID who may benefit from enhanced research and potential treatments', 'Public health agencies involved in managing and studying post-COVID health impacts']
['Lack of detailed text and summary limits understanding of funding sources, scope, and enforcement mechanisms', 'Potential challenges in coordination among federal agencies and research entities without clear authority provisions', 'Uncertainty about oversight and accountability measures due to absence of full legislative text']
The bill was introduced during the 118th Congress and referred to a key Senate committee responsible for health policy. Its failure to advance suggests limited legislative momentum or competing priorities within the Senate during this period. The focus on Long COVID reflects ongoing public health interest in addressing the long-term effects of the COVID-19 pandemic.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['If enacted, the bill could have stimulated increased federal funding and coordination for Long COVID research, potentially accelerating scientific understanding and treatment development.', 'Enhanced research efforts might indirectly impact healthcare providers by informing clinical guidelines and patient care strategies for Long COVID.', 'Failure to pass may delay or reduce federal prioritization of Long COVID research, affecting affected individuals and related health sectors.']
The absence of an official summary and full bill text presents a significant transparency challenge, limiting public and stakeholder understanding of the bill's provisions and potential impacts. The bill's failure to advance past committee referral further restricts insight into legislative deliberations or amendments. Monitoring future legislative efforts on Long COVID research is advisable to assess evolving policy responses.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.